Imaging in hypertensive heart disease

Expert Review of Cardiovascular Therapy

Volumn 9, Issue 2, 2011, Pages 199-209

  Janardhanan, Rajesh ^a   Kramer, Christopher M ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

cardiac magnetic resonance; diastolic function; echocardiography; hypertension; hypertensive heart disease; left ventricular hypertrophy; left ventricular mass; myocardial fibrosis

Indexed keywords

ARTERIAL WALL THICKNESS; BLOOD PRESSURE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); DIASTOLIC DYSFUNCTION; ECHOCARDIOGRAPHY; HEART DEATH; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; NONHUMAN; REVIEW; THREE DIMENSIONAL ECHOCARDIOGRAPHY;

ANIMALS; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER; ECHOCARDIOGRAPHY, THREE-DIMENSIONAL; ENDOMYOCARDIAL FIBROSIS; HEART; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MAGNETIC RESONANCE IMAGING; MYOCARDIAL ISCHEMIA; PROGNOSIS; RADIONUCLIDE IMAGING;

EID: 79952173841     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.10.190     Document Type: Review

References (91)

1. Janardhanan R, Desai AS, Solomon SD. Therapeutic approaches to diastolic dysfunction. Curr. Hypertens. Rep. 11(4), 283-291 (2009).
2. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA 275(20), 1557-1562 (1996). (Pubitemid 26154241)
3. Kannel WB, Gordon T, Castelli WP, Margolis JR. Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study. Ann. Intern. Med. 72(6), 813-822 (1970).
4. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N. Engl. J. Med. 322(22), 1561-1566 (1990). (Pubitemid 20176696)
5. Verdecchia P, Schillaci G, Borgioni C et al. Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy. Am. J. Cardiol. 78(2), 197-202 (1996). (Pubitemid 26244369)
6. Wachtell K, Bella JN, Rokkedal J et al. Change in diastolic left ventricular filling after one year of antihypertensive treatment: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. Circulation 105(9), 1071-1076 (2002). (Pubitemid 34212616)
7. Okin PM, Devereux RB, Jern S et al. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA 292(19), 2343-2349 (2004). (Pubitemid 39491918)
8. Verdecchia P, Schillaci G, Borgioni C et al. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 97(1), 48-54 (1998). (Pubitemid 28036154)
9. McLenachan JM, Henderson E, Morris KI, Dargie HJ. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N. Engl. J. Med. 317(13), 787-792 (1987). (Pubitemid 17133358)
10. Dimopoulos S, Nicosia F, Donati P et al. QT dispersion and left ventricular hypertrophy in elderly hypertensive and normotensive patients. Angiology 59(5), 605-612 (2008).
11. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am. J. Cardiol. 82(8A), 2N-9N (1998). (Pubitemid 28507114)
12. Devereux RB, Wachtell K, Gerdts E et al. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA 292(19), 2350-2356 (2004). (Pubitemid 39491919)
13. Devereux RB, Alonso DR, Lutas EM et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am. J. Cardiol. 57(6), 450-458 (1986). (Pubitemid 16119719)
14. Savage DD, Garrison RJ, Kannel WB et al. The spectrum of left-ventricular hypertrophy in a general-population sample - the Framingham-Study. Circulation 75(1), 26-33 (1987).
15. Li L, Shigematsu Y, Hamada M, Hiwada K. Relative wall thickness is an independent predictor of left ventricular systolic and diastolic dysfunctions in essential hypertension. Hypertens. Res. 24(5), 493-499 (2001). (Pubitemid 33048914)
16. Palmieri V, Wachtell K, Bella JN et al. Usefulness of the assessment of the appropriateness of left ventricular mass to detect left ventricular systolic and diastolic abnormalities in absence of echocardiographic left ventricular hypertrophy: the LIFE study. J. Hum. Hypertens. 18(6), 423-430 (2004). (Pubitemid 38787038)
17. Ganau A, Devereux RB, Roman MJ et al. Patterns of left-ventricular hypertrophy and geometric remodeling in essential-hypertension. J. Am. Coll. Cardiol. 19(7), 1550-1558 (1992).
18. Foppa M, Duncan BB, Rohde LE. Echocardiography-based left ventricular mass estimation. How should we define hypertrophy? Cardiovasc. Ultrasound 3, 17 (2005).
19. Verdecchia P, Schillaci G, Borgioni C et al. Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. J. Am. Coll. Cardiol. 25(4), 871-878 (1995).
20. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann. Intern. Med. 114(5), 345-352 (1991).
21. Savage DD, Drayer JI, Henry WL et al. Echocardiographic assessment of cardiac anatomy and function in hypertensive subjects. Circulation 59(4), 623-632 (1979). (Pubitemid 9154952)
22. Devereux RB, Savage DD, Drayer JI, Laragh JH. Left ventricular hypertrophy and function in high, normal, and low-renin forms of essential hypertension. Hypertension 4(4), 524-531 (1982). (Pubitemid 12017363)
23. Salcedo EE, Gockowski K, Tarazi RC. Left ventricular mass and wall thickness in hypertension. Comparison of M mode and two dimensional echocardiography in two experimental models. Am. J. Cardiol. 44(5), 936-940 (1979). (Pubitemid 10200701)
24. Korner PI, Jennings GL. Assessment of prevalence of left ventricular hypertrophy in hypertension. J. Hypertens. 16(6), 715-723 (1998). (Pubitemid 28247953)
25. Alfakih K, Reid S, Hall A, Sivananthan MU. The assessment of left ventricular hypertrophy in hypertension. J. Hypertens. 24(7), 1223-1230 (2006). (Pubitemid 43948316)
26. Agabiti-Rosei E, Muiesan ML, Salvetti M. Evaluation of subclinical target organ damage for risk assessment and treatment in the hypertensive patients: left ventricular hypertrophy. J. Am. Soc. Nephrol. 17(4 Suppl. 2), S104-S108 (2006).
27. Buck T, Hunold P, Wentz KU, Tkalec W, Nesser HJ, Erbel R. Tomographic three-dimensional echocardiographic determination of chamber size and systolic function in patients with left ventricular aneurysm: comparison to magnetic resonance imaging, cineventriculography, and two-dimensional echocardiography. Circulation 96(12), 4286-4297 (1997). (Pubitemid 28007457)
28. Gutberlet M, Abdul-Khaliq H, Grothoff M et al. [Evaluation of left ventricular volumes in patients with congenital heart disease and abnormal left ventricular geometry. Comparison of MRI and transthoracic 3-dimensional echocardiography]. Rofo 175(7), 942-951 (2003). (Pubitemid 36903560)
29. Kuhl HP, Schreckenberg M, Rulands D et al. High-resolution transthoracic real-time three-dimensional echocardiography: quantitation of cardiac volumes and function using semi-automatic border detection and comparison with cardiac magnetic resonance imaging. J. Am. Coll. Cardiol. 43(11), 2083-2090 (2004). (Pubitemid 38686806)
30. von Bardeleben RS, Kuhl HP, Mohr-Kahaly S, Franke A. Second-generation real-time three-dimensional echocardiography. Finally on its way into clinical cardiology? Z. Kardiol. 93(Suppl. 4), IV56-IV64 (2004).
31. Missouris CG, Forbat SM, Singer DR, Markandu ND, Underwood R, MacGregor GA. Echocardiography overestimates left ventricular mass: a comparative study with magnetic resonance imaging in patients with hypertension. J. Hypertens. 14(8), 1005-1010 (1996). (Pubitemid 26306066)
32. Myerson SG, Montgomery HE, World MJ, Pennell DJ. Left ventricular mass: reliability of M-mode and 2-dimensional echocardiographic formulas. Hypertension 40(5), 673-678 (2002). (Pubitemid 35278604)
33. Bottini PB, Carr AA, Prisant LM, Flickinger FW, Allison JD, Gottdiener JS. Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient. Am. J. Hypertens. 8(3), 221-228 (1995).
34. Papavassiliu T, Kuhl HP, van Dockum W et al. Accuracy of one- and two-dimensional algorithms with optimal image plane position for the estimation of left ventricular mass: a comparative study using magnetic resonance imaging. J. Cardiovasc. Magn. Reson. 6(4), 845-854 (2004). (Pubitemid 40041289)
35. Sakuma H, Fujita N, Foo TK et al. Evaluation of left ventricular volume and mass with breath-hold cine MR imaging. Radiology 188(2), 377-380 (1993). (Pubitemid 23216255)
36. Pattynama PM, Lamb HJ, van der Velde EA, van der Wall EE, de Roos A. Left ventricular measurements with cine and spin-echo MR imaging: a study of reproducibility with variance component analysis. Radiology 187(1), 261-268 (1993). (Pubitemid 23097896)
37. Katz J, Milliken MC, Stray-Gundersen J et al. Estimation of human myocardial mass with MR imaging. Radiology 169(2), 495-498 (1988).
38. Florentine MS, Grosskreutz CL, Chang W et al. Measurement of left ventricular mass in vivo using gated nuclear magnetic resonance imaging. J. Am. Coll. Cardiol. 8(1), 107-112 (1986). (Pubitemid 16094121)
39. Keller AM, Peshock RM, Malloy CR et al. In vivo measurement of myocardial mass using nuclear magnetic resonance imaging. J. Am. Coll. Cardiol. 8(1), 113-117 (1986). (Pubitemid 16094122)
40. Devereux RB, Dahlof B, Gerdts E et al. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. Circulation 110(11), 1456-1462 (2004). (Pubitemid 39238023)
41. Grothues F, Smith GC, Moon JC et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am. J. Cardiol. 90(1), 29-34 (2002). (Pubitemid 34671198)
42. Reichek N, Devereux RB, Rocha RA et al. Magnetic resonance imaging left ventricular mass reduction with fixed-dose angiotensin-converting enzyme inhibitor-based regimens in patients with high-risk hypertension. Hypertension 54(4), 731-737 (2009).
43. Pitt B, Reichek N, Willenbrock R et al. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study. Circulation 108(15), 1831-1838 (2003). (Pubitemid 37296092)
44. Shimizu G, Hirota Y, Kita Y, Kawamura K, Saito T, Gaasch WH. Left ventricular midwall mechanics in systemic arterial hypertension. Myocardial function is depressed in pressure-overload hypertrophy. Circulation 83(5), 1676-1684 (1991).
45. de Simone G, Devereux RB, Koren MJ, Mensah GA, Casale PN, Laragh JH. Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension. Circulation 93(2), 259-265 (1996). (Pubitemid 26031483)
46. Lew WY, LeWinter MM. Regional comparison of midwall segment and area shortening in the canine left ventricle. Circ. Res. 58(5), 678-691 (1986). (Pubitemid 16088290)
47. Axel L, Dougherty L. MR imaging of motion with spatial modulation of magnetization. Radiology 171(3), 841-845 (1989). (Pubitemid 19134952)
48. Young AA, Imai H, Chang CN, Axel L. Two-dimensional left ventricular deformation during systole using magnetic resonance imaging with spatial modulation of magnetization. Circulation 89(2), 740-752 (1994). (Pubitemid 24056202)
49. Clark NR, Reichek N, Bergey P et al. Circumferential myocardial shortening in the normal human left ventricle. Assessment by magnetic resonance imaging using spatial modulation of magnetization. Circulation 84(1), 67-74 (1991).
50. Palmon LC, Reichek N, Yeon SB et al. Intramural myocardial shortening in hypertensive left ventricular hypertrophy with normal pump function. Circulation 89(1), 122-131 (1994). (Pubitemid 24026481)
51. Osman NF, Prince JL. Visualizing myocardial function using HARP MRI. Physics Med. Biol. 45(6), 1665-1682 (2000). (Pubitemid 30408925)
52. Rosen BD, Saad MF, Shea S et al. Hypertension and smoking are associated with reduced regional left ventricular function in asymptomatic: individuals the Multi-Ethnic Study of Atherosclerosis. J. Am. Coll. Cardiol. 47(6), 1150-1158 (2006).
53. Gaasch WH, Zile MR. Left ventricular diastolic dysfunction and diastolic heart failure. Annu. Rev. Med. 55, 373-394 (2004). (Pubitemid 38316733)
54. Aurigemma GP, Gaasch WH. Diastolic heart failure. N. Engl. J. Med. 351(11), 1097-1105 (2004).
55. Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289(2), 194-202 (2003). (Pubitemid 36068707)
56. Wachtell K, Smith G, Gerdts E et al. Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). Losartan Intervention For Endpoint. Am. J. Cardiol. 85(4), 466-472 (2000). (Pubitemid 30089623)
57. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation 105(11), 1387-1393 (2002). (Pubitemid 34260433)
58. Kannel WB, Levy D, Cupples LA. Left ventricular hypertrophy and risk of cardiac failure: insights from the Framingham Study. J. Cardiovasc. Pharmacol. 10(Suppl. 6), S135-S140 (1987).
59. Smith VE, White WB, Meeran MK, Karimeddini MK. Improved left ventricular filling accompanies reduced left ventricular mass during therapy of essential hypertension. J. Am. Coll. Cardiol. 8(6), 1449-1454 (1986). (Pubitemid 17208927)
60. Nishimura RA, Tajik AJ. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone. J. Am. Coll. Cardiol. 30(1), 8-18 (1997). (Pubitemid 27357121)
61. Schillaci G, Pasqualini L, Verdecchia P et al. Prognostic significance of left ventricular diastolic dysfunction in essential hypertension. J. Am. Coll. Cardiol. 39(12), 2005-2011 (2002). (Pubitemid 34628283)
62. Ishida Y, Meisner JS, Tsujioka K et al. Left ventricular filling dynamics: influence of left ventricular relaxation and left atrial pressure. Circulation 74(1), 187-196 (1986). (Pubitemid 16092940)
63. Choong CY, Herrmann HC, Weyman AE, Fifer MA. Preload dependence of Doppler-derived indexes of left ventricular diastolic function in humans. J. Am. Coll. Cardiol. 10(4), 800-808 (1987). (Pubitemid 17163104)
64. Waggoner AD, Bierig SM. Tissue Doppler imaging: a useful echocardiographic method for the cardiac sonographer to assess systolic and diastolic ventricular function. J. Am. Soc. Echocardiogr. 14(12), 1143-1152 (2001). (Pubitemid 33144379)
65. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J. Am. Coll. Cardiol. 30(6), 1527-1533 (1997). (Pubitemid 27486472)
66. Sohn DW, Chai IH, Lee DJ et al. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J. Am. Coll. Cardiol. 30(2), 474-480 (1997).
67. Hurlburt HM, Aurigemma GP, Hill JC et al. Direct ultrasound measurement of longitudinal, circumferential, and radial strain using 2-dimensional strain imaging in normal adults. Echocardiography 24(7), 723-731 (2007). (Pubitemid 47094229)
68. Amundsen BH, Helle-Valle T, Edvardsen T et al. Noninvasive myocardial strain measurement by speckle tracking echocardiography: validation against sonomicrometry and tagged magnetic resonance imaging. J. Am. Coll. Cardiol. 47(4), 789-793 (2006). (Pubitemid 43243102)
69. Narayanan A, Aurigemma GP, Chinali M, Hill JC, Meyer TE, Tighe DA. Cardiac mechanics in mild hypertensive heart disease: a speckle-strain imaging study. Circ. Cardiovasc. Imaging 2(5), 382-390 (2009).
70. Solomon SD, Janardhanan R, Verma A et al. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial. Lancet 369(9579), 2079-2087 (2007). (Pubitemid 46935945)
71. Rathi VK, Doyle M, Yamrozik J et al. Routine evaluation of left ventricular diastolic function by cardiovascular magnetic resonance: a practical approach. J. Cardiovasc. Magn. Reson. 10, 36 (2008).
72. Rathi VK, Biederman RW. Expanding role of cardiovascular magnetic resonance in left and right ventricular diastolic function. Heart Fail. Clin. 5(3), 421-435, vii (2009).
73. Querejeta R, Varo N, Lopez B et al. Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease. Circulation 101(14), 1729-1735 (2000). (Pubitemid 30196635)
74. Conrad CH, Brooks WW, Hayes JA, Sen S, Robinson KG, Bing OH. Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat. Circulation 91(1), 161-170 (1995).
75. Kass DA, Bronzwaer JG, Paulus WJ. What mechanisms underlie diastolic dysfunction in heart failure? Circ. Res. 94(12), 1533-1542 (2004). (Pubitemid 38856960)
76. Martos R, Baugh J, Ledwidge M et al. Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation 115(7), 888-895 (2007). (Pubitemid 46294729)
77. Mizuno R, Fujimoto S, Saito Y, Nakamura S. Non-invasive quantitation of myocardial fibrosis using combined tissue harmonic imaging and integrated backscatter analysis in dilated cardiomyopathy. Cardiology 108(1), 11-17 (2007). (Pubitemid 47014345)
78. Raman SV. The hypertensive heart. An integrated understanding informed by imaging. J. Am. Coll. Cardiol. 55(2), 91-96 (2010).
79. Rudolph A, Abdel-Aty H, Bohl S et al. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J. Am. Coll. Cardiol. 53(3), 284-291 (2009).
80. Moreo A, Ambrosio G, De Chiara B et al. Influence of myocardial fibrosis on left ventricular diastolic function: noninvasive assessment by cardiac magnetic resonance and echo. Circ. Cardiovasc. Imaging 2(6), 437-443 (2009).
81. Iles L, Pfluger H, Phrommintikul A et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J. Am. Coll. Cardiol. 52(19), 1574-1580 (2008).
82. Brilla CG, Funck RC, Rupp H. Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation 102(12), 1388-1393 (2000).
83. Marcus ML, Koyanagi S, Harrison DG, Doty DB, Hiratzka LF, Eastham CL. Abnormalities in the coronary circulation that occur as a consequence of cardiac hypertrophy. Am. J. Med. 75(3A), 62-66 (1983). (Pubitemid 13009936)
84. Poe ND, Eber LM, Norman AS, Selin CE, Terao EN. Myocardial images in nonacute coronary and noncoronary heart diseases. J. Nucl. Med. 18(1), 18-23 (1977). (Pubitemid 8019769)
85. Picano E, Palinkas A, Amyot R. Diagnosis of myocardial ischemia in hypertensive patients. J. Hypertens. 19(7), 1177-1183 (2001). (Pubitemid 32595272)
86. Cannon RO 3rd, Watson RM, Rosing DR, Epstein SE. Angina caused by reduced vasodilator reserve of the small coronary arteries. J. Am. Coll. Cardiol. 1(6), 1359-1373 (1983). (Pubitemid 13054121)
87. Panting JR, Gatehouse PD, Yang GZ et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N. Engl. J. Med. 346(25), 1948-1953 (2002). (Pubitemid 34651354)
88. Bernhardt P, Levenson B, Albrecht A, Engels T, Strohm O. Detection of cardiac small vessel disease by adenosine-stress magnetic resonance. Int. J. Cardiol. 121(3), 261-266 (2007). (Pubitemid 47445793)
89. Alfakih K, Walters K, Jones T, Ridgway J, Hall AS, Sivananthan M. New gender-specific partition values for ECG criteria of left ventricular hypertrophy: recalibration against cardiac MRI. Hypertension 44(2), 175-179 (2004). (Pubitemid 39014235)
90. Schillaci G, Verdecchia P, Porcellati C, Cuccurullo O, Cosco C, Perticone F. Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension 35(2), 580-586 (2000). (Pubitemid 30108152)
91. Levy D, Labib SB, Anderson KM, Christiansen JC, Kannel WB, Castelli WP. Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation 81(3), 815-820 (1990).(Pubitemid 20090377)